CRANBURY, N.J.--(BUSINESS WIRE)--OncLive® will present the State of the Science Summit™: Advanced Non-Small Cell Lung Cancer (NSCLC) on Feb. 15 at the Hilton Anatole in Dallas, Texas, from 5:30 to 9:00 p.m. The event will be chaired by David Mason, M.D., chief, thoracic surgery and lung transplantation, Baylor University Medical Center.
This intensive educational program will offer insight from the leading oncologists in the Dallas, Texas, region. The following specialists will share their expertise on pressing issues including biomarkers in NSCLC, surgical resection in the era of biomarker driven therapy, immunotherapy beyond frontline therapy and proton therapy in lung cancer.
Speakers for this meeting are:
- Claude Denham, M.D., oncologist, Baylor University Medical Center
- Kartik Konduri, M.D., oncologist, Baylor University Medical Center
- Ravi Salgia, M.D., Ph.D., oncologist, City of Hope
- Gary Schwartz, M.D., thoracic surgeon, Baylor University Medical Center
- George R. Simon, M.D., oncologist, MD Anderson Cancer Center
- Michelle Shiller, DO, pathologist, Baylor University Medical Center
The State of the Science Summit™ is a premier conference series hosted by OncLive® featuring medical experts from across the nation. Aiming to discuss current treatment options, each summit integrates academic and community-based physicians and health care professionals across key disciplines ranging from medical and surgical oncology to hematology.
Registration is free and open to all health care professionals. Food and beverages will be served. For more information and to register, visit www.onclive.com/meetings/soss or contact Allison Cooper at ACooper@curetoday.com.
A digital platform of resources for practicing oncologists, OncLive® offers professionals information they can use to help provide the best patient care. OncLive.com is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. Michael J. Hennessy Associates, Inc., is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication dedicated entirely on cancer care. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.